Age, Biography and Wiki
Ben Goldacre (Ben Michael Goldacre) was born on 20 May, 1974 in London, United Kingdom, is a British physician, academic and science writer (born 1974). Discover Ben Goldacre's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 49 years old?
Popular As |
Ben Michael Goldacre |
Occupation |
Author, journalist, physician, science writer and scientist |
Age |
49 years old |
Zodiac Sign |
Taurus |
Born |
20 May 1974 |
Birthday |
20 May |
Birthplace |
London, United Kingdom |
Nationality |
United Kingdom
|
We recommend you to check the complete list of Famous People born on 20 May.
He is a member of famous Author with the age 49 years old group.
Ben Goldacre Height, Weight & Measurements
At 49 years old, Ben Goldacre height not available right now. We will update Ben Goldacre's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Michael Goldacre
Susan Goldacre (née Traynor) |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Ben Goldacre Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Ben Goldacre worth at the age of 49 years old? Ben Goldacre’s income source is mostly from being a successful Author. He is from United Kingdom. We have estimated Ben Goldacre's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
Author |
Ben Goldacre Social Network
Timeline
Goldacre is the son of Michael Goldacre, a professor of public health at the University of Oxford, and Susan Traynor (stage name Noosha Fox), lead singer of 1970s pop band Fox, both of whom are Australian.
He is the nephew of Robyn Williams, a science journalist, and the great-great-grandson of Henry Parkes, politician and journalist who is considered the father of the Australian Federation.
Goldacre was educated at Magdalen College School, Oxford.
Ben Michael Goldacre (born 20 May 1974) is a British physician, academic and science writer.
He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford.
He is a founder of the AllTrials campaign and OpenTrials to require open science practices in clinical trials.
He studied medicine at Magdalen College, Oxford, where he obtained a first-class Bachelor of Arts honours degree during his preclinical studies in 1995 in Physiological Sciences.
He edited the Oxford student magazine, Isis.
Goldacre was a visiting researcher in cognitive neuroscience at the University of Milan, working on fMRI brain scans of language and executive function.
He also received a Master of Arts degree in philosophy from King's College London in 1997.
Although challenging Andrew Wakefield's views about immunisation, Goldacre repeatedly defended Wakefield against an investigation by The Sunday Times into Wakefield's fraudulent 1998 paper in The Lancet, prompting criticism from the newspaper's reporter Brian Deer.
Following his studies at the Universities of Oxford and Milan, Goldacre studied clinical medicine at UCL Medical School, qualifying as a medical doctor in 2000 with a Bachelor of Medicine, Bachelor of Surgery (MB, BS) degree.
Goldacre is known in particular for his Bad Science column in The Guardian, which he wrote between 2003 and 2011, and is the author of four books: Bad Science (2008), a critique of irrationality and certain forms of alternative medicine; Bad Pharma (2012), an examination of the pharmaceutical industry, its publishing and marketing practices, and its relationship with the medical profession; I Think You'll Find It's a Bit More Complicated Than That, a collection of his journalism; and Statins, about evidence-based medicine.
Goldacre frequently delivers free talks about bad science; he describes himself as a "nerd evangelist".
Goldacre was known for his weekly column, "Bad Science", which ran in the Saturday edition of The Guardian from 2003 until November 2011.
The column focused on pseudoscience and the misuse of science.
Topics discussed included marketing, the media, quackery, problems with the pharmaceutical industry, and its relationship with medical journals.
Goldacre has criticised anti-immunisation campaigners (particularly followers of Andrew Wakefield such as Melanie Phillips and Jeni Barnett), Brain Gym, bogus positive MRSA swab stories in tabloid newspapers, publication bias, and the makers of the product Penta Water.
He has been a particularly hardline critic of the nutritionist Gillian McKeith.
While investigating McKeith's membership of the American Association of Nutritional Consultants, Goldacre obtained a professional membership on behalf of his late cat, Henrietta, from the same institution for $60.
Goldacre passed the Member of the Royal College of Psychiatrists (MRCPsych) Part II examinations in December 2005 and became a member of the Royal College of Psychiatrists.
Writing in The Guardian in September 2005, Goldacre argued:
"The paper always was and still remains a perfectly good small case series report, but it was systematically misrepresented as being more than that, by media that are incapable of interpreting and reporting scientific data."
In February 2007, McKeith agreed to stop using the title "Doctor" in her advertising, following a complaint to the Advertising Standards Authority by a "Bad Science" reader.
In an interview with Richard Saunders of the podcast Skeptic Zone, Goldacre said, "Nutritionists are particularly toxic because they are the alternative therapists who, more than any other, misrepresent themselves as being men and women of science."
He was made a research fellow at the Institute of Psychiatry in London in 2008, and a Guardian research fellow at Nuffield College, Oxford, in 2009.
In 2008, Matthias Rath, a vitamin entrepreneur, sued Goldacre and The Guardian over three articles, in which Goldacre criticised Rath's promotion of vitamin pills to AIDS sufferers in South African townships.
Rath dropped his action in September 2008 and was ordered to pay initial costs of £220,000 to The Guardian.
As of September 2008, the paper was seeking full costs of £500,000, and Goldacre had expressed an interest in writing a book about Rath and South Africa, as a chapter on the subject had to be cut from his book while the litigation proceeded.
As Wakefield appeared before a General Medical Council hearing in 2008, Goldacre stepped up his support for the research:
"I will now defend the heretic Dr Andrew Wakefield. The media are fingering the wrong man, and they know who should really take the blame: in MMR, journalists and editors have constructed their greatest hoax to date."
After Wakefield's falsifications of the data came to light, Goldacre continued to lambast journalists for credulity and sensationalism:
The chapter was reinstated in a later edition of the book, and also published online in 2009.
Goldacre continues to cite Rath as a proponent of harmful pseudoscience.
In 2012, Goldacre was appointed a Wellcome Trust Research Fellow in Epidemiology at the London School of Hygiene & Tropical Medicine.
In 2015, Goldacre moved to the Nuffield Department of Primary Care Health Sciences's Centre for Evidence-Based Medicine at the University of Oxford, joining a project funded by a grant from the Laura and John Arnold Foundation.
In 2022, he became the first Bennett Professor of Evidence-Based Medicine and director of Oxford's newly-established Bennett Institute for Applied Data Science.
As of 2016, according to Scopus and Google Scholar his most cited articles have been published in NeuroReport, the European Journal of Preventive Cardiology, the British Medical Journal, The Lancet, and PLOS ONE.
In 2020, Goldacre was, with Liam Smeeth, the principal investigator of the OpenSAFELY collaboration which created a software platform to analyse the records of 24 million NHS patients to provide detailed risk factors for hospital deaths from COVID-19.